Advancing the treatment of MDS and AML: An update from ASH 2021
touchCONGRESS for touchONCOLOGY
Listen to Prof. Pierre Fenaux (France) review key data presented at ASH 2021 on emerging treatments for patients with higher-risk MDS and newly diagnosed AML and offer his insights on their potential impact on future clinical practice, alongside those from Dr Esther Oliva (Italy) and Prof. Andrew Wei (Australia).
OVERVIEW
Data review with Prof. Fenaux (0:00)
Expert interviews with Prof. Fenaux, Dr Oliva and Prof. Wei, answering the questions below
INTERVIEW QUESTIONS
What have we learned about targeting specific mutations in MDS and how will this impact the…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.